Andrew M. Dahl's most recent trade in Edwards Lifesciences Corp was a trade of 5,670 Employee Stock Option (Right to Acquire) done . Disclosure was reported to the exchange on May 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Corp | Andrew M. Dahl | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 5,670 | 5,670 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Andrew M. Dahl | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 3,335 | 8,106 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Andrew M. Dahl | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.30 per share. | 22 Feb 2025 | 176 | 4,684 (0%) | 0% | 73.3 | 12,901 | Common Stock |
| Syra Health Corp - Ordinar... | Andrew M. Dahlem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 9,102 | 20,683 | - | - | Stock Options | |
| Syra Health Corp - Ordinar... | Andrew M. Dahlem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2024 | 11,581 | 11,581 | - | - | Stock Options | |
| Edwards Lifesciences Corp | Andrew M. Dahl | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2024 | 2,920 | 4,690 (0%) | 0% | 0 | Common Stock | |
| Syra Health Corp - Ordinar... | Andrew M. Dahlem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2023 | 10,000 | 10,000 | - | - | Stock Options |